Impact of educational intervention on the pattern and incidence of potential drug-drug interactions in Nepal
- PMID: 25136400
- PMCID: PMC4134843
- DOI: 10.4321/s1886-36552009000400008
Impact of educational intervention on the pattern and incidence of potential drug-drug interactions in Nepal
Abstract
Objective: To study the impact of educational intervention on the pattern and incidence of potential drug-drug interactions (DDIs).
Method: All patients admitted to Internal Medicine wards of Manipal Teaching Hospital during the study period were included. Patient details were collected using a patient profile form and the datum from the filled forms was analyzed using Micromedex electronic database. An intervention was carried out through a presentation during clinical meeting and personal discussion. The target groups for the intervention included doctors and the nurses.
Results: Altogether 435 patients during preintervention and 445 during postintervention were studied. The incidence of potential DDIs was 53% (preintervention) and 41% (postintervention) [chi-square =11.27, p=0.001]. The average number of drugs per patient was 8.53 (pre-intervention) and 7.32 (post-intervention) [t=3.493, p=0.001]. Sixty-four percent of the potential DDIs were of 'Moderate' type and 58% had a 'Delayed' onset in both the phases. Seventy percent of the potential DDIs during the pre-intervention phase and 61% during post-intervention phase had a 'Good' documentation status. Pharmacokinetic mechanism accounted for 45% of the potential DDIs during preintervention and 36% in the post-intervention phase. Cardiovascular drugs accounted for 36% of the potential DDIs during pre-intervention and 33.2% during post-intervention phase. Furosemide was the high risk drug responsible for DDIs in both phases. The most common potential DDIs observed were between amlodipine and atenolol (4.82%) (preintervention) and frusemide and aspirin (5.20%) (postintervention).
Conclusion: There was an association between potential DDIs and age, sex, and polypharmacy.
Keywords: Continuing; Drug Interactions; Education; Inpatients; Nepal.
Conflict of interest statement
None.
References
-
- Lee A, Stockley IH. Drug interactions. In: Walker R, Edwards C, editors. Clinical Pharmacy and Therapeutics. 3rd edition. Philadelphia: Churchill Livingstone; 2003. pp. 21–31.
-
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. J Am Med Assoc. 2003;289:2560–2572. - PubMed
-
- Boston Collaborative Drug Survelliance Program: Adverse drug interactions. J Am Med Assoc. 1972;220:1238–1239. - PubMed
-
- Classen DC, Pestotnick SL, Evans RS, Bukke JP. Computerized surveillance of adverse drug events in hospital patients. J Am Med Assoc. 1991;266:2847–2851. - PubMed
-
- Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc. 1988;36:1092–1098. - PubMed
LinkOut - more resources
Full Text Sources